Certara stock.

The company showed -9% earnings growth last quarter, while sales growth came in at 15%. Keep an eye out for the company's next round of numbers on or around Mar. 1. The company earns the No. 3 ...Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT. At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...

PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share.Total cost of revenue for the third quarter of 2023 was $35.9 million, an increase of $3.1 million from $32.8 million in the third quarter of 2022, primarily due to a $3.0 million increase in ...

Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.

Dec 3, 2020 · PRINCETON, NJ.—. December 3, 2020 – Certara, Inc. (“Certara”) today announced the launch of its initial public offering of 24,390,000 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 14,630,000 shares of common stock and certain selling ... Certara, Inc. Common Stock (CERT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.16 Des 2020 ... Certara today announced that it closed its upsized initial public offering of 33413250 shares of common stock at $23.00 per share.CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …

Certara has launched a series of interactive educational webinars to teach users how to build PK and PK/PD models in Phoenix. This series is called the Phoenix Modeling Language School or PML School. The series will cover scenarios such as simultaneous fitting of IV and PO data, target-mediated drug disposition, enterohepatic recirculation ...

CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth.

Complete Certara Inc. stock information by Barron's. View real-time CERT stock price and news, along with industry-best analysis.Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...Legal Name Certara, Inc. Stock Symbol NASDAQ:CERT. Company Type For Profit. Contact Email [email protected]. Phone Number 415-237-8272. Certara is a pharmaceutical company that accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include …Mason Slaine CERT stock SEC Form 4 insiders trading. Mason has made over 9 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Mason sold 250,000 units of CERT stock worth $3,890,000 on 14 November 2022.. The largest trade Mason's ever made was selling 620,668 units of Certara stock …Certara, Inc. (“Certara”), a global leader in biosimulation, today announced a proposed underwritten public offering of 17 million shares of its common stock being offered by selling stockholders. Additionally, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to 2,550,000 additional shares of common ...

Certara Reports Fourth Quarter and Full Year 2022 Financial Results. Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency. PRINCETON, N.J.— March 1, 2023– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2022 and issued guidance ...Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?The company showed -9% earnings growth last quarter, while sales growth came in at 15%. Keep an eye out for the company's next round of numbers on or around Mar. 1. The company earns the No. 3 ...Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensCertara, Inc. (CERT Quick Quote CERT - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole?While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.5 brokerages have issued 1-year price objectives for Elanco Animal Health's stock. Their ELAN share price targets range from $9.50 to $16.00. On average, they anticipate the company's share price to reach …

Mar 29, 2021 · PRINCETON, N.J.– March 29, 2021 –Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 11,500,000 shares of its common stock by certain existing stockholders at a public offering price of $25.00 per share. The closing includes 1,500,000 shares sold upon full ...

Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...Here are 5 tips to streamline developing a detailed SOC that will help relieve some of the last-minute stress: 1. During the kickoff meeting, ask your regulatory affairs representative whether a detailed SOC is required. Frequently, a high-level overview of changes and the rationale for these changes is sufficient.1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 17, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation...The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.The estimated Net Worth of Richard M. Traynor is at least $8.76 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,938,988 and over the last 3 years he sold CERT stock worth over $5,825,760.In other Certara news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $14.60, for a total transaction of $747,870.40. Following the transaction, the insider now directly owns 128,883 shares in the company, valued at $1,881,691.80.Nov 21, 2023 · Certara Stock Performance. Certara stock opened at $14.71 on Tuesday. The stock’s 50 day moving average price is $13.73 and its 200 day moving average price is $16.78. The firm has a market capitalization of $2.35 billion, a PE ratio of -70.05, a price-to-earnings-growth ratio of 1.15 and a beta of 1.51. The company has a debt-to-equity ratio ...

Here are three high-yield tech stocks worth considering right now. With its stock down around 10% over the past year and a dividend yielding 3.4% annually as of this writing, semiconductor giant ...

Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.

Certara is a former municipality in the district of Lugano in the canton of Ticino in Switzerland. On 14 April 2013 the former municipalities of Bogno, Cadro, Carona, Certara, Cimadera, Valcolla and Sonvico merged into the municipality of Lugano. History.Certara went public in December 2020, raising $337 million in an IPO. The firm sells biosimulation software and related services to biopharmaceutical firms and regulatory agencies worldwide. CERT ...8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price.11 Des 2020 ... The EQT-backed drug simulation software maker's shares jumped as much as 72% following the company's IPO.The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Certara's software platform Simcyp group awarded two new grants from US FDA Certara downgraded at Jefferies on growth headwinds Certara Non-GAAP EPS of $0.12 misses by $0.01, revenue of $90.45M ...The estimated Net Worth of William F Feehery is at least $74.9 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $41,776,274 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Certara Reports Fourth Quarter and Full Year 2022 Financial Results. Annual Revenue Grows 17% on a Reported Basis and 20% at Constant Currency. PRINCETON, N.J.— March 1, 2023– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the fourth quarter and full year of 2022 and issued guidance ...

The estimated Net Worth of Richard M. Traynor is at least $9.96 Million dollars as of 6 March 2023. Mr Traynor owns over 10,000 units of Certara stock worth over $4,353,865 and over the last 2 years he sold CERT stock worth over $5,603,360.Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.Certara Inc. 1699 South Hanley Road. St. Louis, Missouri 63144-2319. Phone 314 647-1099. Industry Software. Sector Technology. Fiscal Year-end N/A. Revenue.Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. These figures are ...Instagram:https://instagram. cloa etfstocks btcsgood eye insuranceastron aerospace stock What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the info you need to form an effective investment strategy. So ... tradoavtenyseamerican ng If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.In connection with the offering, the Selling Stockholders have granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares. No shares are being sold by Certara. The Selling Stockholders will receive all of the proceeds from this offering. The last reported sale price of Certara’s common stock on August 11, 2022 was ... trading stock software 1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.In connection with the offering, the Selling Stockholders have granted the underwriter a 30-day option to purchase up to 1,050,000 additional shares. No shares are being sold by Certara. The Selling Stockholders will receive all of the proceeds from this offering. The last reported sale price of Certara’s common stock on August 11, 2022 was ...The estimated Net Worth of Leif E Pedersen is at least $5.41 Million dollars as of 11 September 2023. Mr Pedersen owns over 51,224 units of Certara stock worth over $1,801,784 and over the last 2 years he sold CERT stock worth over $3,311,582. In addition, he makes $295,397 as Pres of Software at Certara.